On the Synergistic Effects of Ligand-Mediated and Phage-Intrinsic Properties During In Vivo Selection

Advances in Genetics

Volumn 69, Issue C, 2010, Pages 115-133

  Driessen, Wouter H P ^a   Bronk, Lawrence F ^a   Edwards, Julianna K ^a   Proneth, Bettina ^a   Souza, Glauco R ^b   Decuzzi, Paolo ^b,c   Pasqualini, Renata ^a   Arap, Wadih ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CELL SURFACE RECEPTOR; LIGAND; PEPTIDE LIBRARY;

ARTICLE; BACTERIOPHAGE; BIOLOGICAL MODEL; BIOMECHANICS; CELL MEMBRANE; CLINICAL TRIAL; GENETICS; METABOLISM;

BACTERIOPHAGES; BIOMECHANICS; CAPSID PROTEINS; CELL MEMBRANE; CLINICAL TRIALS AS TOPIC; LIGANDS; MODELS, BIOLOGICAL; PEPTIDE LIBRARY; RECEPTORS, CELL SURFACE;

EID: 77956160920     PISSN: 00652660     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2660(10)69005-0     Document Type: Book

References (62)

1. Arap W., Kolonin M.G., Trepel M., Lahdenranta J., Cardo-Vila M., Giordano R.J., Mintz P.J., Ardelt P.U., Yao V.J., Vidal C.I., Chen L., Flamm A., et al. Steps toward mapping the human vasculature by phage display. Nat. Med. 2002, 8(2):121-127.
2. Barbas C. Phage Display: A Laboratory Manual 2001, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. C. Barbas (Ed.).
3. Brown D.M., Pellecchia M., Ruoslahti E. Drug identification through in vivo screening of chemical libraries. Chembiochem 2004, 5(6):871-875.
4. Caravan P., Das B., Dumas S., Epstein F.H., Helm P.A., Jacques V., Koerner S., Kolodziej A., Shen L., Sun W.C., Zhang Z. Collagen-targeted MRI contrast agent for molecular imaging of fibrosis. Angew. Chem. Int. Ed. Engl. 2007, 46(43):8171-8173.
5. Cardo-Vila M., Giordano R.J., Sidman R.L., Bronk L.F., Fan Z., Mendelsohn J., Arap W., Pasqualini R. From combinatorial peptide selection to drug prototype (II): Targeting the epidermal growth factor receptor pathway. Proc Natl Acad Sci USA 2010, 107(11):5118-5123.
6. Christianson D.R., Ozawa M.G., Pasqualini R., Arap W. Techniques to decipher molecular diversity by phage display. Methods Mol. Biol. 2007, 357:385-406.
7. De Mestre N.J., Russel W.B. Low-Reynolds-number translation of a slender cylinder near a plane wall. J. Eng. Math. 1975, 9(2):81-91.
8. Decuzzi P., Ferrari M. The receptor-mediated endocytosis of nonspherical particles. Biophys. J. 2008, 94(10):3790-3797.
9. Decuzzi P., Lee S., Bhushan B., Ferrari M. A theoretical model for the margination of particles within blood vessels. Ann. Biomed. Eng. 2005, 33(2):179-190.
10. Decuzzi P., Causa F., Ferrari M., Netti P.A. The effective dispersion of nanovectors within the tumor microvasculature. Ann. Biomed. Eng. 2006, 34(4):633-641.
11. Decuzzi P., Pasqualini R., Arap W., Ferrari M. Intravascular delivery of particulate systems: Does geometry really matter?. Pharm. Res. 2009, 26(1):235-243.
12. Dickson M., Gagnon J.P. Key factors in the rising cost of new drug discovery and development. Nat. Rev. Drug. Discov. 2004, 3(5):417-429.
13. Evans E.A., Calderwood D.A. Forces and bond dynamics in cell adhesion. Science 2007, 316(5828):1148-1153.
14. Fang J., Sawa T., Maeda H. Factors and mechanism of "EPR" effect and the enhanced antitumor effects of macromolecular drugs including SMANCS. Adv. Exp. Med. Biol. 2003, 519:29-49.
15. Forgacs O.L., Mason S.G. Particle motions in sheared suspensions: IX. Spin and deformation of threadlike particles. J. Colloid Sci. 1959, 14(5):457-472.
16. Forgacs O.L., Mason S.G. Particle motions in sheared suspensions: X. Orbits of flexible threadlike particles. J. Colloid Sci. 1959, 14(5):473-491.
17. Geng Y., Dalhaimer P., Cai S., Tsai R., Tewari M., Minko T., Discher D.E. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2007, 2(4):249-255.
18. Gestwicki J.E., Cairo C.W., Strong L.E., Oetjen K.A., Kiessling L.L. Influencing receptor-ligand binding mechanisms with multivalent ligand architecture. J. Am. Chem. Soc. 2002, 124(50):14922-14933.
19. Giordano R.J., Cardo-Vila M., Salameh A., Anobom C.D., Zeitlin B.D., Hawke D.H., Valente A.P., Almeida F.C., Nor J.E., Sidman R.L., Pasqualini R., Arap W. From combinatorial peptide selection to drug prototype (I): Targeting the vascular endothelial growth factor receptor pathway. Proc. Natl. Acad. Sci. USA 2010, 107(11):5112-5117.
20. Goncalves E., Kitas E., Seelig J. Binding of oligoarginine to membrane lipids and heparan sulfate: Structural and thermodynamic characterization of a cell-penetrating peptide. Biochemistry 2005, 44(7):2692-2702.
21. Hajitou A., Pasqualini R., Arap W. Vascular targeting: Recent advances and therapeutic perspectives. Trends Cardiovasc. Med. 2006, 16(3):80-88.
22. Helms B.A., Reulen S.W., Nijhuis S., de Graaf-Heuvelmans P.T., Merkx M., Meijer E.W. High-affinity peptide-based collagen targeting using synthetic phage mimics: From phage display to dendrimer display. J. Am. Chem. Soc. 2009, 131(33):11683-11685.
23. Hoffman R.M. Tumor-targeting amino acid auxotrophic Salmonella typhimurium. Amino Acids 2009, 37(3):509-521.
24. Houghten R.A., Pinilla C., Giulianotti M.A., Appel J.R., Dooley C.T., Nefzi A., Ostresh J.M., Yu Y., Maggiora G.M., Medina-Franco J.L., Brunner D., Schneider J. Strategies for the use of mixture-based synthetic combinatorial libraries: Scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods. J. Comb. Chem. 2008, 10(1):3-19.
25. Iyer A.K., Khaled G., Fang J., Maeda H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov. Today 2006, 11(17-18):812-818.
26. Johns M., George A.J., Ritter M.A. In vivo selection of sFv from phage display libraries. J. Immunol. Methods 2000, 239(1-2):137-151.
27. Khalil A.S., Ferrer J.M., Brau R.R., Kottmann S.T., Noren C.J., Lang M.J., Belcher A.M. Single M13 bacteriophage tethering and stretching. Proc. Natl. Acad. Sci. USA 2007, 104(12):4892-4897.
28. Kiessling L.L., Gestwicki J.E., Strong L.E. Synthetic multivalent ligands as probes of signal transduction. Angew. Chem. Int. Ed. Engl. 2006, 45(15):2348-2368.
29. Kolonin M.G., Sun J., Do K.A., Vidal C.I., Ji Y., Baggerly K.A., Pasqualini R., Arap W. Synchronous selection of homing peptides for multiple tissues by in vivo phage display. FASEB J. 2006, 20(7):979-981.
30. Krag D.N., Shukla G.S., Shen G.P., Pero S., Ashikaga T., Fuller S., Weaver D.L., Burdette-Radoux S., Thomas C. Selection of tumor-binding ligands in cancer patients with phage display libraries. Cancer Res. 2006, 66(15):7724-7733.
31. Lesko L.J. Paving the critical path: How can clinical pharmacology help achieve the vision?. Clin. Pharmacol. Ther. 2007, 81(2):170-177.
32. Levitan B. Stochastic modeling and optimization of phage display. J. Mol. Biol. 1998, 277(4):893-916.
33. Li H., DeRosier D.J., Nicholson W.V., Nogales E., Downing K.H. Microtubule structure at 8 A resolution. Structure 2002, 10(10):1317-1328.
34. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 2001, 41:189-207.
35. Maeda H. SMANCS and polymer-conjugated macromolecular drugs: Advantages in cancer chemotherapy. Adv. Drug Deliv. Rev. 2001, 46(1-3):169-185.
36. Maeda H., Bharate G.Y., Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur. J. Pharm. Biopharm. 2009, 71(3):409-419.
37. Mammen M., Choi S.-K., Whitesides G.M. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Ed. Engl. 1998, 37(20):2754-2794.
38. Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986, 46(12 Pt 1):6387-6392.
39. Merkel R., Nassoy P., Leung A., Ritchie K., Evans E. Energy landscapes of receptor-ligand bonds explored with dynamic force spectroscopy. Nature 1999, 397(6714):50-53.
40. Molenaar T.J., Michon I., de Haas S.A., van Berkel T.J., Kuiper J., Biessen E.A. Uptake and processing of modified bacteriophage M13 in mice: Implications for phage display. Virology 2002, 293(1):182-191.
41. Nakashima Y., Wiseman R.L., Konigsberg W., Marvin D.A. Primary structure and sidechain interactions of PFL filamentous bacterial virus coat protein. Nature 1975, 253(5486):68-71.
42. Ozawa M.G., Zurita A.J., Dias-Neto E., Nunes D.N., Sidman R.L., Gelovani J.G., Arap W., Pasqualini R. Beyond receptor expression levels: The relevance of target accessibility in ligand-directed pharmacodelivery systems. Trends Cardiovasc. Med. 2008, 18(4):126-132.
43. Park J.W., Hong K., Kirpotin D.B., Colbern G., Shalaby R., Baselga J., Shao Y., Nielsen U.B., Marks J.D., Moore D., Papahadjopoulos D., Benz C.C. Anti-HER2 immunoliposomes: Enhanced efficacy attributable to targeted delivery. Clin. Cancer Res. 2002, 8(4):1172-1181.
44. Park J.H., von Maltzahn G., Zhang L., Derfus A.M., Simberg D., Harris T.J., Ruoslahti E., Bhatia S.N., Sailor M.J. Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. Small 2009, 5(6):694-700.
45. Pasqualini R., Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature 1996, 380(6572):364-366.
46. Pasqualini R., Moeller B.J., Arap W. Leveraging molecular heterogeneity of the vascular endothelium for targeted drug delivery and imaging. Semin. Thromb. Hemost. 2010, 36(3):343-351.
47. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141(1):39-51.
48. Smith G.P., Petrenko V.A. Phage display. Chem. Rev. 1997, 97(2):391-410.
49. Stover C.A., Cohen C. The motion of rodlike particles in the pressure-driven flow between two flat plates. Rheol. Acta 1990, 29:192.
50. Tasciotti E., Liu X., Bhavane R., Plant K., Leonard A.D., Price B.K., Cheng M.M., Decuzzi P., Tour J.M., Robertson F., Ferrari M. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat. Nanotechnol. 2008, 3(3):151-157.
51. Tornberg, Shelley Simulating the dynamics and interactions of flexible fibers in stokes flows. J. Comput. Phys. 2004, 196:8-40.
52. Trepel M., Pasqualini R., Arap W. Chapter 4: Screening phage-display peptide libraries for vascular targeted peptides. Methods Enzymol. 2008, 445:83-106.
53. Wang Y.A., Yu X., Overman S., Tsuboi M., Thomas G.J., Egelman E.H. The structure of a filamentous bacteriophage. J. Mol. Biol. 2006, 361(2):209-215.
54. Wiseman R.L., Berkowitz S.A., Day L.A. Different arrangements of protein subunits and single-stranded circular DNA in the filamentous bacterial viruses fd and Pf1. J. Mol. Biol. 1976, 102(3):549-561.
55. Woodcock J., Woosley R. The FDA critical path initiative and its influence on new drug development. Annu. Rev. Med. 2008, 59:1-12.
56. Woolley A.T., Kelly R.T. Deposition and characterization of extended SIngle-stranded DNA molecules on surfaces. Nano Lett. 2001, 1(7):345-348.
57. Zhang X., Wojcikiewicz E., Moy V.T. Force spectroscopy of the leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. Biophys. J. 2002, 83(4):2270-2279.
58. Zhao M., Yang M., Li X.M., Jiang P., Baranov E., Li S., Xu M., Penman S., Hoffman R.M. Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 2005, 102(3):755-760.
59. Zhao M., Yang M., Ma H., Li X., Tan X., Li S., Yang Z., Hoffman R.M. Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res. 2006, 66(15):7647-7652.
60. Ziegler A., Blatter X.L., Seelig A., Seelig J. Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis. Biochemistry 2003, 42(30):9185-9194.
61. Zimmermann K., Hagedorn H., Heuck C.C., Hinrichsen M., Ludwig H. The ionic properties of the filamentous bacteriophages Pf1 and fd. J. Biol. Chem. 1986, 261(4):1653-1655.
62. Zou J., Dickerson M.T., Owen N.K., Landon L.A., Deutscher S.L. Biodistribution of filamentous phage peptide libraries in mice. Mol. Biol. Rep. 2004, 31(2):121-129.